3 results
To determine the improvement in symptoms of constipation in subjects receiving treatment with oxycodone/naloxone prolonged release tablets (OXN) compared to subjects receiving oxycodone prolonged release tablets (OXY) based on the Bowel Function…
Primary: To assess the proportion of patients with intervention failure at 12 months after dose reduction, defined as patients who have restarted their initial dose due to (expected) loss of major molecular response.
Objective: The primary aim of the study is to demonstrate that cervical administered ITB is a safe treatment of spasticity of the UE without deterioration of pulmonary function, respiration and sleep-related breathing disorders.